The Susan and Leonard Feinstein Inflammatory Bowel Disease Clinical Center Opens

The Mount Sinai Hospital recently opened the Susan and Leonard Feinstein Inflammatory Bowel Disease Clinical Center at 17 East 102nd Street, a facility created to provide comprehensive care in one location for pediatric and adult patients. Inflammatory Bowel Disease (IBD) is a general classification of conditions that cause inflammation of the intestines. An estimated 1.4 million people in the United States have Crohn’s disease and ulcerative colitis. Read more

GI Field Forges Ahead in Treating IBD

More than one million Americans suffer from inflammatory bowel diseases (IBD), primarily Crohn’s disease and ulcerative colitis. Affecting people of any age, race or gender, IBD causes chronic inflammation of all or part of the digestive tract. Crohn’s can strike in any part of the system, while ulcerative colitis is only found in the large bowel. Patients’ symptoms vary widely, but the most common are diarrhea, abdominal pain or both.

As with many other digestive disorders, patients with IBD are constantly on a quest to find the right treatment regimen to relieve the symptoms that interfere with their everyday lives. This search for effective IBD treatments was one of the many topics my colleagues and I discussed during Digestive Disease Week® (DDW), the world’s largest gathering of physicians and researchers in the fields of gastroenterology, hepatology, endoscopy and gastrointestinal surgery.

Read more